As of May 27
| -0.0039 / -1.15%|
The 5 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +643.83% increase from the last price of 0.34.
The current consensus among 6 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.